Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of Interferon-Free Therapies for Chronic Hepatitis C: A Systematic Review of All Randomized Clinical Trials.

Clinical drug investigation - 1 Jul 2017

Ferreira Vinicius L, Tonin Fernanda S, Assis Jarek Nayara A, Ramires Yohanna, Pontarolo Roberto

Abstract excerpt

BACKGROUND AND OBJECTIVES: Second-generation direct-acting antivirals (DAAs) have recently arisen as more effective and safer treatments for chronic hepatitis C. These drugs can be combined into treatments without interferon (IFN), and are therefore called IFN-free therapies. OBJECTIVE: The objective of this study systematic review was to evaluate the efficacy of IFN-free therapies for the treatment of chronic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Randomized Controlled Trials as Topic

Share to Sustained Virologic Response

Source

Identifiers

PMID: 28409482
DOI: 10.1007/s40261-017-0521-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of Interferon-Free Therapies for Chronic Hepatitis C: A Systematic Review of All Randomized Clinical Trials.PMID 28409482Read ↗

Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives.Semantic proximity Read ↗

Interferon-free regimens for hepatitis C: combine and conquer.Semantic proximity Read ↗

Direct-acting antiviral drugs for the treatment of chronic hepatitis C virus infection: Interferon free is now.Semantic proximity Read ↗

Current therapy for chronic hepatitis C: The role of direct-acting antivirals.Semantic proximity Read ↗

Interferon free therapy with direct acting antivirals for HCV.Semantic proximity Read ↗

Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review.Semantic proximity Read ↗

Chronic Hepatitis C Treatment with Direct-Acting Antiviral Agents in a Real-Life Setting.Semantic proximity Read ↗

Treatment of hepatitis C: a systematic review.Semantic proximity Read ↗

The hepatitis C revolution part 1: antiviral treatment options.Semantic proximity Read ↗

Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil.Semantic proximity Read ↗

Optimal IFN-free therapy in treatment-naïve patients with HCV genotype 1 infection.Semantic proximity Read ↗

Advances in hepatitis C therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.